SC
IOVA icon

Saturna Capital’s Iovance Biotherapeutics IOVA Stock Holding History

Saturna Capital’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,553
Closed -$44.6K – 155
2025
Q3 		$44.6K Hold
20,553
– – ﹤0.01% 157
2025
Q2 		$35.4K Hold
20,553
– – ﹤0.01% 157
2025
Q1 		$68.4K Hold
20,553
– – ﹤0.01% 149
2024
Q4 		$152K Hold
20,553
– – ﹤0.01% 157
2024
Q3 		$193K Buy
20,553
+1,353
+7% +$12.8K ﹤0.01% 157
2024
Q2 		$154K Sell
19,200
-6,000
-24% -$64.3K ﹤0.01% 165
2024
Q1 		$373K Hold
25,200
– – 0.01% 143
2023
Q4 		$205K Sell
25,200
-1,000
-4% -$5.23K ﹤0.01% 170
2023
Q3 		$119K Buy
26,200
+6,000
+30% +$39.2K ﹤0.01% 171
2023
Q2 		$142K Hold
20,200
– – ﹤0.01% 163
2023
Q1 		$123K Buy
+20,200
New +$139K ﹤0.01% 157

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return